311
40. Brandman S, Ko JP. Pulmonary nodule detection,
characterization, and management with multidetector
computed tomography. J Thorac Imaging. 2011;26(2):90-105.
41. Siegelman SS, Zerhouni EA, Leo FP, Khouri NF, Stitik FP. CT
of the solitary pulmonary nodule. AJR Am J Roentgenol.
1980;135(1):1-13.
42. Zwirewich CV, Vedal S, Miller RR, Muller NL. Solitary pulmonary
nodule: high-resolution CT and radiologic-pathologic
correlation. Radiology. 1991;179(2):469-476.
43. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule
enhancement
at
CT:
multicenter
study.
Radiology.
2000;214(1):73-80.
44. Christensen JA, Nathan MA, Mullan BP, et al. Characterization
of the solitary pulmonary nodule: 18F-FDG PET versus nodule-
enhancement CT. AJR Am J Roentgenol 2006;187(5):1361-
1367.
45. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung
cancer action project: a summary of the findings on baseline
screening. Oncologist. 2001;6(2):147-152.
46. Hollings N, Shaw P. Diagnostic imaging of lung cancer. Eur
Respir J. 2002;19(4):722-742.
47. Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary
nodule: a cooperative study. Radiology. 1986;160(2):319-
327.
48. Godoy MC, Naidich DP. Subsolid pulmonary nodules and
the spectrum of peripheral adenocarcinomas of the lung:
recommended interim guidelines for assessment and
management. Radiology. 2009;253(3):606-622.
49. MacMahon H, Austin JHM, Gamsu G, Herold CJ, Jett JR, Naidich
DP, Patz EF, Swensen SJ. Guidelines for Management of Small
Pulmonary Nodules Detected on CT Scans: A Statement from
the Fleischner Society. Radiology 2005, 237(2): 395–400.
50. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM,
Pistolesi M, Goo JM, Macchiarini P, Crapo JD, Herold CJ, Austin
JH, Travis WD. Recommendations for the Management of
Subsolid Pulmonary Nodules Detected at CT: A Statement from
the Fleischner Society. Radiology 2013, 266(1): 304-317.
51. Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS. Small
stage I cancers of the lung: genuineness and curability. Lung
Cancer. 2003;39(3):327-330.
52. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y,Yamada T,
Hirohashi S, Kondo H, Shimosato Y. Small Adenocarcinoma
of the Lung. Histologic Characteristics and Prognosis. CANCER
1995, 75 (12): 2844-2852.
53. Asamura H. Minimally invasive approach to early, peripheral
adenocarcinoma with ground-glass opacity appearance. Ann
Thorac Surg. 2008 Feb;85(2):S701-4.
54. Godoy MC, Naidich DP. Overview and strategic management
of subsolid pulmonary nodules. J Thorac Imaging.
2012;27(4):240-248.
55. Lee HJ, Goo JM, Lee CH, et al. Nodular ground-glass opacities on
thin-section CT: size change during follow-up and pathological
results. Korean J Radiol 2007;8(1):22-31.
56. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity
detected by low-dose helical CT. Chest 2002;121(5):1464-
1467
57. Park CM, Goo JM, Lee HJ, et al. Nodular ground-glass opacity
at thin-section CT: histologic correlation and evaluation of
change at follow-up. Radiographics 2007;27(2):391-408.
58. Humphrey LL, Teutsch S, Johnson M. Lung Cancer Screening
with Sputum Cytologic Examination, ChestRadiography, and
Computed Tomography: An Update forthe U.S. Preventive
Services Task Force. Ann Intern Med. 2004;140:740-753.
59. Canals M, Barros A, Barros P, Triviño R, Berrios R, Bannura F.
Hallazgos de imagen en Tomografía Computada de voluntarios
fumadores de larga data. Rev Chil Radiol; 2009, 15(3):
105-109.
60. Gil R, Florenzano M, Ibarra C, Baehr F, Del Solar A, Parada MT,
Rodríguez JC. Cáncer Pulmonar Prevención y Pesquiza Precoz.
Rev Med Clin Condes 2011; 22(4): 500-507.
61. Clavero J.M., Huete A. y Aparicio R. Detección Precoz de Cáncer
Pulmonar en población de alto riesgo. Rev Chil Enf Respir 2005;
21: 270
62. H, de Koning H, Vernhout R, Nackaerts K, Prokop M, Weenink
C, Lammers JW, Groen H, Oudkerk M, van Klaveren R. Nodule
managemente protocol of the NELSON randomised lung cancer
screening trial. Lung Cancer. 2006;54(2):177-84.
63. Solomon CG, Gould MK. Lung-Cancer Screening with Low-Dose
Computed Tomography. NEJM ,2014; 371(19): 1813–1820.
64. Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K,
Weenink C, Groen HJM, Lammers JJ, Aerts JG, Scholten ET,van
Rosmalen J, Mali W, Oudkerk M, de Koning HJ. Characteristics
of Lung Cancers Detected by Computer Tomography Screening
in the Randomized NELSON Trial. Am J Respir Crit Care Med Vol
187, Iss. 8, pp 848–854, Apr 15, 2013
65. Shlomi D, D Shlomi, Ben-Avi R, Balmor GR, Onn A, Peled N.
Screening for lung cancer: time for large-scale screening by
chest computed tomography. Eur Resp J 2014; 44(1):217–238.
66. Manser R, Wright G, Hart D, Byrnes G, Campbell D, Wainer Z, Tort
S. Surgery for local and locally advanced non-small cell lung
cancer. Cochrane Database of Systematic Reviews 2005, Issue
1. Art. No.: CD004699. DOI: 10.1002/14651858. CD004699.
pub2.
67. Lardinois D, De Leyn P, Van Schil P, Rami Porta R, Waller D. ESTS
guidelines for intraoperative lymph node staging in non-small
cell lung cancer. European Journal of Cardio-Thoracic Surgery
2006, 30(5): 787–792.
68. Allen MS, Darling GE, Pechet TTV, et al. Morbidity and mortality
of major pulmonary resections in patients with early-stage
lung cancer: Initial results of the randomized, prospective
ACOSOG Z0030 Trial. Ann Thorac Surg. 2006;81:1013-20.
69. Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional
Limited resection for Selected Patients with T1N0M0
Non-Small-Cel Lung Cancer: a Single Institution Study. J
Thorac Cardiovasc Surg 1997;114: 347-53
70. Asamura H, Grunenwald D. Extent of surgical resection for stage
I and II lung cancer.. Pass HI, Ball D, Scagliotti GV (eds) The IASLC
Multidisciplinary Approach to Thoracic Oncology. Aurora, CO:
[Nódulos Pulmonares - Dr. José Miguel Clavero R.]